Satellite cells senescence in limb muscle of severe patients with COPD

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Thériault, Marie Eve ^a   Paré, Marie Ève ^a   Maltais, François ^a   Debigaré, Richard ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL NUCLEUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE REGENERATION; SATELLITE CELL; SENESCENCE; SOUTHERN BLOTTING; TELOMERE; VASTUS LATERALIS MUSCLE;

AGED; BLOTTING, SOUTHERN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SATELLITE CELLS, PERINEURONAL; TELOMERE;

EID: 84862195345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039124     Document Type: Article

References (55)

1. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Authier FJ, et al. (1998) Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. Int J Mol Med 2: 69-73.
2. Tisdale MJ, (2002) Cachexia in cancer patients. Nat Rev Cancer 2: 862-871.
3. Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, et al. (1996) Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 98: 1703-1708.
4. Brooks SV, Faulkner JA, (1994) Skeletal muscle weakness in old age: underlying mechanisms. Med Sci Sports Exerc 26: 432-439.
5. Tiao G, Fagan JM, Samuels N, James JH, Hudson K, et al. (1994) Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 94: 2255-2264.
6. Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, et al. (2003) Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 124: 83-89.
7. Gosselink R, Troosters T, Decramer M, (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153: 976-980.
8. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, et al. (2002) Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 809-813.
9. Wust RC, Degens H, (2007) Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2: 289-300.
10. Shefer G, Van de Mark DP, Richardson JB, Yablonka-Reuveni Z, (2006) Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev Biol 294: 50-66.
11. Charge SB, Rudnicki MA, (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238.
12. Mauro A, (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493-495.
13. Snow MH, (1978) An autoradiographic study of satellite cell differentiation into regenerating myotubes following transplantation of muscles in young rats. Cell Tissue Res 186: 535-540.
14. Decramer M, de Bock V, Dom R, (1996) Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153: 1958-1964.
15. Gosker HR, Kubat B, Schaart G, van der Vusse GJ, Wouters EF, et al. (2003) Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 22: 280-285.
16. Hawke TJ, Garry DJ, (2001) Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534-551.
17. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, et al. (1995) Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220: 194-200.
18. Greider CW, (1996) Telomere length regulation. Annu Rev Biochem 65: 337-365.
19. Harley CB, Futcher AB, Greider CW, (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460.
20. O'Connor MS, Carlson ME, Conboy IM, (2009) Differentiation rather than aging of muscle stem cells abolishes their telomerase activity. Biotechnol Prog.
21. Decary S, Hamida CB, Mouly V, Barbet JP, Hentati F, et al. (2000) Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord 10: 113-120.
22. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2010) Global Strategy for the Diagnosis, Management and Prevention of COPD.
23. Mostert R, Goris A, Weling-Scheepers C, Wouters EFM, Schols AMW, (2000) Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. 94: 859-867.
24. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J pp. 5-40.
25. Heymsfield SB, Matthews D, (1994) Body composition: research and clinical advances-1993 A.S.P.E.N. research workshop. JPEN J Parenter Enteral Nutr 18: 91-103.
26. Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR, et al. (2007) Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176: 261-269.
27. Lindstrom M, Thornell LE, (2009) New multiple labelling method for improved satellite cell identification in human muscle: application to a cohort of power-lifters and sedentary men. Histochem Cell Biol.
28. Partridge TA, (2002) Cells that participate in regeneration of skeletal muscle. Gene Ther 9: 752-753.
29. Blomstrand E, Celsing F, Friden J, Ekblom B, (1984) How to calculate human muscle fibre areas in biopsy samples-methodological considerations. Acta Physiol Scand 122: 545-551.
30. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, et al. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 89: 10114-10118.
31. Ponsot E, Kadi F, (2008) Signal modelization for improved precision of assessment of minimum and mean telomere lengths. Electrophoresis 29: 542-544.
32. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, et al. (1997) Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther 8: 1429-1438.
33. Debigare R, Maltais F, (2008) The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol 105: 751-753.
34. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, et al. (1998) Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 629-634.
35. Kim HC, Mofarrahi M, Hussain SN, (2008) Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 3: 637-658.
36. Eliason G, Abdel-Halim S, Arvidsson B, Kadi F, Piehl-Aulin K, (2009) Physical performance and muscular characteristics in different stages of COPD. Scand J Med Sci Sports 19: 865-870.
37. Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas JM, et al. (2001) Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1734-1739.
38. Harley CB, Villeponteau B, (1995) Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5: 249-255.
39. Tsuji T, Aoshiba K, Nagai A, (2006) Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 174: 886-893.
40. Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, et al. (2009) Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 179: 566-571.
41. Houben JM, Mercken EM, Ketelslegers HB, Bast A, Wouters EF, et al. (2009) Telomere shortening in chronic obstructive pulmonary disease. Respir Med 103: 230-236.
42. Mui TS, Man JM, McElhaney JE, Sandford AJ, Coxson HO, et al. (2009) Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging. J Am Geriatr Soc 57: 2372-2374.
43. Lansdorp PM, (2005) Major cutbacks at chromosome ends. Trends Biochem Sci 30: 388-395.
44. Baird DM, (2008) Telomeres II. Exp Gerontol 43: 15-19.
45. Hastie ND, Allshire RC, (1989) Human telomeres: fusion and interstitial sites. Trends Genet 5: 326-331.
46. Saretzki G, von ZT, (2002) Replicative aging, telomeres, and oxidative stress. Ann N Y Acad Sci 959: 24-29.
47. Richter T, von ZT, (2007) A continuous correlation between oxidative stress and telomere shortening in fibroblasts. Exp Gerontol 42: 1039-1042.
48. Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ, (2008) Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med 44: 235-246.
49. Cattan V, Mercier N, Gardner JP, Regnault V, Labat C, et al. (2008) Chronic oxidative stress induces a tissue-specific reduction in telomere length in CAST/Ei mice. Free Radic Biol Med 44: 1592-1598.
50. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, et al. (2003) Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1664-1669.
51. Rahman I, Skwarska E, Macnee W, (1997) Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52: 565-568.
52. Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut C, (2002) Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 20: 1123-1129.
53. van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, et al. (2006) Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 38: 1543-1552.
54. Rahman I, Skwarska E, Macnee W, (1997) Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52: 565-568.
55. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, et al. (2001) Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1114-1118.